LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Search

iRhythm Technologies Inc

Cerrado

SectorSanidad

178.57 2.74

Resumen

Variación precio

24h

Actual

Mínimo

170.33

Máximo

182.01

Métricas clave

By Trading Economics

Ingresos

9M

-5.2M

Ventas

6.2M

193M

Margen de beneficios

-2.702

Empleados

2,000

EBITDA

7.7M

2.4M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+25.21% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-425M

5.4B

Apertura anterior

175.83

Cierre anterior

178.57

Noticias sobre sentimiento de mercado

By Acuity

75%

25%

344 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

iRhythm Technologies Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 dic 2025, 23:54 UTC

Principales Movimientos del Mercado

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 dic 2025, 19:08 UTC

Adquisiciones, fusiones, absorciones

Correction to Alphabet to Buy Intersect Article

22 dic 2025, 17:21 UTC

Adquisiciones, fusiones, absorciones

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 dic 2025, 16:46 UTC

Adquisiciones, fusiones, absorciones

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 dic 2025, 23:50 UTC

Charlas de Mercado

Nikkei May Decline as Yen Rebounds -- Market Talk

22 dic 2025, 23:42 UTC

Charlas de Mercado

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 dic 2025, 22:31 UTC

Ganancias

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 dic 2025, 22:31 UTC

Ganancias

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 dic 2025, 22:30 UTC

Ganancias

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

22 dic 2025, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

22 dic 2025, 21:37 UTC

Adquisiciones, fusiones, absorciones

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 dic 2025, 21:36 UTC

Adquisiciones, fusiones, absorciones

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 dic 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Capricorn to Acquire Prospective Package From Tempest Minerals

22 dic 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 dic 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 dic 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 dic 2025, 20:09 UTC

Charlas de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 dic 2025, 19:56 UTC

Charlas de Mercado

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 dic 2025, 19:49 UTC

Adquisiciones, fusiones, absorciones

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 dic 2025, 19:23 UTC

Charlas de Mercado

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 dic 2025, 19:23 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 dic 2025, 19:02 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

22 dic 2025, 19:02 UTC

Charlas de Mercado

Precious Metals Climb to New Heights -- Market Talk

22 dic 2025, 18:45 UTC

Charlas de Mercado

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 dic 2025, 18:30 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 dic 2025, 18:23 UTC

Adquisiciones, fusiones, absorciones

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 dic 2025, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

22 dic 2025, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

22 dic 2025, 17:06 UTC

Adquisiciones, fusiones, absorciones

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Comparación entre iguales

Cambio de precio

iRhythm Technologies Inc previsión

Precio Objetivo

By TipRanks

25.21% repunte

Estimación a 12 Meses

Media 218.08 USD  25.21%

Máximo 244 USD

Mínimo 185 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para iRhythm Technologies Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

14 ratings

12

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

104.78 / 137.91Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

344 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat